BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37987270)

  • 1. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.
    Riaz K; Suneel S; Hamza Bin Abdul Malik M; Kashif T; Ullah I; Waris A; Di Nicola M; Mazza M; Sani G; Martinotti G; De Berardis D
    Diseases; 2023 Nov; 11(4):. PubMed ID: 37987270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
    Feduccia AA; Mithoefer MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):221-228. PubMed ID: 29524515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
    Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
    Bahji A; Forsyth A; Groll D; Hawken ER
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review.
    Szafoni S; Więckiewicz G; Pudlo R; Gorczyca P; Piegza M
    Psychiatr Pol; 2022 Aug; 56(4):823-836. PubMed ID: 37074831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder.
    Lewis BR; Byrne K
    Focus (Am Psychiatr Publ); 2023 Jul; 21(3):247-256. PubMed ID: 37404966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
    Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
    J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.
    Inouye A; Wolfgang A
    Cureus; 2022 Jun; 14(6):e26402. PubMed ID: 35915689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns.
    Baldo BA
    Arch Toxicol; 2024 May; ():. PubMed ID: 38743292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials.
    Yang J; Wang N; Luo W; Gao J
    Psychiatry Res; 2024 Jun; 339():116043. PubMed ID: 38896930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
    Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
    Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Focus (Am Psychiatr Publ); 2023 Jul; 21(3):306-314. PubMed ID: 37404974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials.
    Stauffer CS; Brown MR; Adams D; Cassity M; Sevelius J
    Front Psychiatry; 2022; 13():932605. PubMed ID: 36299539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.
    Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC
    Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
    Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Front Psychiatry; 2019; 10():650. PubMed ID: 31572236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.
    Price CM; Feduccia AA; DeBonis K
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):464-469. PubMed ID: 36018231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MDMA-assisted therapy for PTSD].
    Thorarinsdottir H; Gudmundsdottir B; Sigurdsson E
    Laeknabladid; 2024 May; 110(5):254-261. PubMed ID: 38713560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
    J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.